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Purpose of the software: Clinical management of high grade gliomas (HGG) 
often involves antiangiogenic therapies using monoclonal antibodies, mainly 
against VGEF. Responses to this treatment are highly heterogeneous, with 
similar cohorts of patients behaving as “responders” or “non-responders”. It 
would be then very useful to discriminate by non invasive criteria the two 
populations as early as possible, to tailor treatment accordingly.
Here we provide a software package to predict in vivo and automatically the 
treatment outcome of mice bearing implanted Gl621 tumors to anti‑VGEF 
therapy, using DWI and T2w data sets.
Methods/Implementation: We evaluated treatment response in 13 mice 
bearing implanted Gl261 tumors on a 7T MR scanner (RECIST criteria [1], 
mAb against VEGF B20‑4.1, 5mg/Kg twice weekly for 8 weeks). MRI stud‑
ies included T2w and DWI performed sequentially at 3/4 day intervals until 
completion of treatment or obvious, treatment independent, tumor growth. 
Fisher’s discriminant analysis [2] was then applied to Day‑1 and Day‑2 of treat‑
ment data set in order to find the linear projection that best discriminates the 
pixels as belonging to “responder” or “non-responder” animals to anti‑VGEF 
treatment. The discriminant function obtained may be used later to classify 
additional data into one of the two classes.
Our package is implemented in MATLAB and is able to accept DWI and T2w 
data sets from mouse brains, providing automatically a prediction of the new 
image in a scale of “response rate” 0 (non-responder) ‑ 100 (responder).
Features illustrated at the exhibit: We illustrate the operation of the program 
(Fig. 1) with a set of sample DWI and T2w images from the mouse brains us‑
ing the data base described in Methods. The user may enter an external data 
base into the application or use preeexisting data base already configured in 
the software package. Features include: Data input, Data Exploration, Train 
new model (Fig. 2), Classify a subject, results expressed as “response rate” (Fig. 
3), and Export report.
This software provides a protocol for the prediction of therapy response to 
antiangiogenic therapy in mouse glioma models, based on non invasive pa‑
rameters as T2w and DWI.
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